Oct 19th, 2022

Guideline updates, late-breaking science and more to add to your Monday itinerary

audience

Early ablation bests medication in treatment naïve AFib patients

audience shot

First-in-class aminopeptidase-A inhibitor fails to reduce treatment-resistant hypertension

Manesh Patel

#AHA 22 Closing Session: That’s a wrap

Getty Images 1388100332

Congratulations to the winners of the Wellness Challenge and Scavenger Hunt

puppy snugglers

Special Recognition to the Hinsdale Humane Society

audience shot

Trial results shed light on tool for assessing VTE risk, routine anticoagulation for non-hospitalized COVID patients, and clinical outcomes of open vs. endovascular surgery for advanced PAD

LBS 05 panelists

Trials’ results highlight supplement ineffectiveness and potential for novel therapies to lower lipoprotein(a), reduce CKD progression

Medtech

Medtech is getting smarter — and so is patient care

med tech checking fluids in a hospital

New digital hub offers professional education to complement lifelong learning

AHA speaker dais

Uncovering novel approaches in heart failure science

Aha22 Sm 2334

Trial results report on benefits of radial artery for CABG, use of prophylactic methylprednisolone and ECMO for patients in cardiogenic shock

Screen Shot 2022 11 06 At 10 45 03 Am

Science, medicine must be a ‘relentless force’ in fighting misinformation